
With 35 different in-home health diagnostic tests now on offer, Everlywell raises $50 million to expand
“The company has a host of competitors across all of its offerings, ranging from Modern Fertility and Future Family, which are both focused on women’s fertility, to 23andMe, the juggernaut of genetics testing that has raised more than $750 million for its gene-testing services.”
April 16 2019